Clinical efficacy of Pudilanxiaoyankoufuye in treatment of chronic pelvic inflammation

Li WANG,Jin-xing LIU,Shi-qian ZHANG
DOI: https://doi.org/10.11816/cn.ni.2015-152038
2015-01-01
Abstract:OBJECTIVE To evaluate the clinical effect of Pudilanxiaoyankoufuye used for auxiliary treatment of chronic pelvic inflammation and explore new therapy for the chronic pelvic inflammation .METHODS A total of 60 patients with pelvic inflammation who were treated in the outpatient department from Feb 2014 to Jan 2015 were enrolled in the study and randomly divided into the control group and the treatment group ,with 30 cases in each . The control group was treated with oral administration of levofloxacin and metronidazole ,while the treatment group was given additional Pudilanxiaoyankoufuye on the basis of the treatment of the control group .The clinical effects and adverse reactions were observed and compared between the two groups of patients .RESULTS The anal‐ysis of the comprehensive efficacy showed that the effective rate of treatment of the treatment group was 90 .00% , significantly higher than 60 .00% of the control group (χ2 =7 .200 ,P<0 .05);the effective rate of evaluation of TCM symptoms was 96 .67% in the treatment group ,significantly higher than 66 .67% in the control group (χ2 =9 .017 ,P<0 .05) .The hemorheological indexes were decreased after the treatment ,and they were remarkably im‐proved as compared with those before the treatment (P<0 .05) ,however ,there was no significant difference be‐tween the two groups .CONCLUSION Pudilanxiaoyankoufuye can achieve significant effect on treatment of the chronic pelvic inflammation ,and it is worthy to be promoted in the hospital .
What problem does this paper attempt to address?